WHO ICTRP trial

A clinical trial to determine if antibiotics prevent chest infections in…

ACTRN12623000958684 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting

Key facts

Trial ID ACTRN12623000958684
Public title A clinical trial to determine if antibiotics prevent chest infections in patients with brain injuries requiring life support in the intensive care unit
Scientific title The Prophylaxis against Early Ventilator Associated Lower Respiratory Tract Infection (PREVENT LRTI) trial. A phase 2 multi-centre, randomized, double-blind, placebo-controlled parallel group clinical trial.
Primary sponsor Medical Research Institute of New Zealand
Secondary sponsors The Australian and New Zealand Intensive Care Research Centre, Monash University
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Recruiting
Study type Interventional
Phase Phase 2
Countries Australia;New Zealand
Conditions Lower respiratory tract infection;Mechanical ventilation;Acute brain injury;Ventilator associated pneumonia; Lower respiratory tract infection Mechanical ventilation Acute brain injury Ventilator associated pneumonia;Infection - Studies of…
Interventions Study treatments will be commenced as soon as possible following randomisation. Patients allocated to the intervention group will receive four doses of 1 gram of ceftriaxone made up to a total of 100mL in 0.9% sodium chloride administered…
Registration date Apr 9, 2023
Target size 360
Secondary IDs Nil known
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations